WELL CHILD/PEDIATRIC AND ADOLESCENT

American Academy of Pediatrics (AAP) Updated Guidance for Palivizumab Prophylaxis Among, Infants and Young Children at Increased Risk of Hospitalizations for Respiratory Syncytial Virus Infection. Pediatrics Vol. 134, Number 2, August 2014, pp 415 - 420 ................
................